Acro Biomedical (ACBM) Shareholder's Equity Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40.87% |
| Sep 30, 2025 | -42.26% |
| Jun 30, 2025 | -36.66% |
| Mar 31, 2025 | -35.22% |
| Dec 31, 2024 | -34.96% |
| Sep 30, 2024 | -35.77% |
| Jun 30, 2024 | -34.47% |
| Mar 31, 2024 | -34.35% |
| Dec 31, 2023 | -33.41% |
| Sep 30, 2023 | -32.41% |
| Jun 30, 2023 | -25.37% |
| Mar 31, 2023 | -22.41% |
| Dec 31, 2022 | -15.22% |
| Sep 30, 2022 | -17.41% |
| Jun 30, 2022 | -15.36% |
| Mar 31, 2022 | -13.63% |
| Dec 31, 2021 | -18.01% |
| Sep 30, 2021 | -22.95% |
| Jun 30, 2021 | -6.26% |
| Mar 31, 2021 | -1.65% |
| Dec 30, 2020 | 5.05% |
| Sep 30, 2020 | 13.39% |
| Jun 30, 2020 | 214.17% |
| Mar 31, 2020 | 282.70% |
| Dec 31, 2019 | 236.04% |
| Sep 30, 2019 | 293.78% |
| Jun 30, 2019 | 381.16% |
| Mar 31, 2019 | 390.50% |
| Sep 30, 2018 | 251.37% |